SCHEMBL14156997

SCHEMBL14156997

O=c1c(Oc2ccc([N+](=O)[O-])c(F)c2)c(C(F)(F)F)oc2cc(O)ccc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.62
▸ ESR1 P03372 5/20 0.61
▸ ESR2 Q92731 5/20 0.61
▸ TTR P02766 1/20 0.54
▸ ALDH1A1 P00352 6/20 0.48
▸ HTT P42858 2/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ NPC1 O15118 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ KIF11 P52732 4/20 0.47
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ POLB P06746 1/20 0.46
▸ MAPT P10636 4/20 0.45
▸ KDM4E B2RXH2 3/20 0.45
▸ GLA P06280 3/20 0.45
▸ GAA P10253 3/20 0.45
▸ HPGD P15428 3/20 0.45
▸ THRB P10828 1/20 0.45
▸ CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14157131 0.92 LMNA (0.62) LMNAESR1ESR2TTRALDH1A1
SCHEMBL14156942 0.92 LMNA (0.64) LMNAESR1ESR2TTRALDH1A1
SCHEMBL14157000 0.83 LMNA (0.56) LMNAESR1ESR2TTRALDH1A1
SCHEMBL3723950 0.79 LMNA (0.76) LMNAESR1ESR2TTRALDH1A1
SCHEMBL12325802 0.79 ESR1 (0.78) LMNAESR1ESR2TTRALDH1A1
SCHEMBL13856884 0.79 LMNA (0.76) LMNAESR1ESR2TTRALDH1A1
SCHEMBL27225472 0.78 LMNA (0.79) LMNAESR1ESR2TTRALDH1A1
SCHEMBL14158220 0.77 LMNA (0.77) LMNAESR1ESR2TTRALDH1A1
SCHEMBL14156914 0.77 LMNA (1.00) LMNAESR1ESR2TTRALDH1A1
SCHEMBL14157022 0.76 LMNA (0.71) LMNAESR1ESR2TTRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012170371-A1 COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS N30 PHARMACEUTICALS, LLC (US) 2012-12-13 — — WO disclosed
Send feedback